BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15485168)

  • 1. [When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis].
    Danielsson A
    Lakartidningen; 2004 Sep; 101(38):2862. PubMed ID: 15485168
    [No Abstract]   [Full Text] [Related]  

  • 2. [New reference interval for ALAT does not identify subclinical liver disease. Lower limit than the proposed should be used for medical considerations!].
    Kechagias S; Ekstedt M; Mathiesen UL; Franzén L
    Lakartidningen; 2004 Sep; 101(38):2884-7. PubMed ID: 15485172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-alcoholic fatty liver].
    Zwimpfer J
    Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the clinical picture of fatty degeneration of the liver and fatty liver].
    Teichmann W; Lindemann A
    Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
    [No Abstract]   [Full Text] [Related]  

  • 5. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 6. [Steatosis of the liver. Biopsy cases].
    Petersen P
    Ugeskr Laeger; 1967 Aug; 129(31):988-90. PubMed ID: 5626248
    [No Abstract]   [Full Text] [Related]  

  • 7. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biopsy and metabolic findings in blood donors having elevated aminotransferases].
    Hanefeld M; Renger F; Bobach G; Thomas K; Simon H; Haller H
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:127-8. PubMed ID: 5402569
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.
    Kunde SS; Lazenby AJ; Clements RH; Abrams GA
    Hepatology; 2005 Sep; 42(3):650-6. PubMed ID: 16037946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with NASH? HAIR is some help.
    Phillips H; Balart LA
    Am J Gastroenterol; 2003 Feb; 98(2):500. PubMed ID: 12591077
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of fatty liver with essential phospholipids].
    Arendt R; Nowotny P; Teichmann W
    Z Gesamte Inn Med; 1970 Jul; 25(13):587-9. PubMed ID: 5523267
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is NAFLD an incidentaloma?
    Tarantino G
    Gastroenterology; 2006 Mar; 130(3):1014-5. PubMed ID: 16530549
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trouble with biopsies..
    Baumann U; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):122. PubMed ID: 16819390
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
    Amarapurkar DN; Patel ND
    Trop Gastroenterol; 2004; 25(3):130-4. PubMed ID: 15682660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elevated transaminases - what to do if everything was done?].
    Lepper PM; Dufour JF
    Praxis (Bern 1994); 2009 Mar; 98(6):330-4. PubMed ID: 19291640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
    Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
    Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.